How much does a box of Sotolasib (AMG510) cost? Imitation Sotolaxibu is greatly reduced!

Sotorasib, also known as AMG510, is a targeted inhibitor designed to treat a specific type of tumor. It is a drug that targets the KRAS G12C mutation, a mutation that is common in many cancers. The KRAS G12C mutation causes a cascade of abnormal cell signaling that drives tumor growth and spread.

Sotoracib is currently not available for purchase in China because the drug has not yet been marketed in the country. Therefore, patients need to obtain sotoraxib through overseas channels. In the overseas market, there are two options for sotorasibu: original drug and generic drug. Original drugs, especially the European and Hong Kong versions, are quite expensive, often reaching tens of thousands.

But relatively speaking, the price of foreign generic drugs is more affordable. For example, among the generic drugs in Laos, the prices of two brands, Lucius and Daxiong, have dropped significantly recently and are now sold for only between 1,000 and 2,000 yuan, saving patients a lot of money. It is worth noting that these generic drugs are very similar to the original drugs in terms of drug ingredients.

Sotorasiib blocks abnormal cell signaling pathways by specifically inhibiting the activity of KRAS G12C protein, thereby inhibiting the growth and proliferation of tumor cells. Compared with traditional chemotherapy and radiotherapy, sotoraxib has a more precise mechanism of action and can more effectively inhibit tumor growth while reducing damage to healthy tissue.

Sotoraxib is often used to treat advanced tumors, particularly in patients who are unable to receive standard treatments or who have progressed despite other treatment options. It is usually given to patients in the form of oral medications, and an individualized treatment plan is developed based on the patient's specific situation and tumor characteristics.

Although sotoracib has shown potential in tumor treatment, it may still cause some adverse reactions, including but not limited to respiratory infection, nausea, diarrhea, rash, etc. Therefore, before using sotorasiib, doctors will evaluate the patient's overall condition and inform the patient of possible adverse reactions and how to monitor and manage them.